ARTICLE | Clinical News
DNA/MVA vaccine: Completed Phase I/II enrollment
January 21, 2013 8:00 AM UTC
GeoVax completed enrollment of 9 HIV-infected patients with suppressed viremia who started anti-retroviral (ART) therapy within 18 months of a negative HIV antibody test in the open-label, U.S. Phase ...